Clarassance has announced that Therabron Therapeutics is the new name of the company, which incorporates the company’s mission to develop protein therapeutics for the treatment of respiratory diseases.

“Our board of directors decided to change the name to mark the company’s escalation into the clinical phase in which multiple clinical trials will be performed,” said Dr. Aprile Pilon, founder and CEO of Therabron Therapeutics. “We think this new name will serve us well as we move forward in developing products to provide long-term improvement in a wide range of respiratory diseases.”